The 2nd BD&L Summit for Life Sciences – The 2nd BD&L Summit for Life Sciences

In order to effectively evaluate any new business development opportunities and ensure that the true value of a transaction has been realized, while forecasting the probability of both development and commercial success, life science companies need to ensure the right internal experts are involved in the evaluation process. This calls for the development and continuous improvement of a formal process that will allow organizations to efficiently and effectively evaluate, negotiate, manage, and close a transaction.

The 2nd BD&L Summit for Life Sciences serves as an open forum for cross-functional business development teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.

Top Five Reasons to Attend:

  1. Explore flexible partnership models spanning the breadth of drug discovery and development
  2. Consider Implications of Today’s Reimbursement Environment on the Deal-Making Landscape
  3. Hear how to create a unique position of leverage during negotiations with multiple parties
  4. Explore patent litigation issues and trends and their impact on life science BD&L
  5. Identify key business goals and map out a clear strategy for potential M&As with respect to tax inversion, consolidation, divestitures, and narrowing strategic focus to maximize portfolio value

Who Should Attend:

This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:

  • Business Development
  • Mergers and Acquisitions
  • Licensing
  • Strategic Alliance/Alliance Management
  • Intellectual Property and Patent Counsel
  • Search and Evaluation
  • Due Diligence
  • External Innovation
  • Transactions
  • Portfolio Management
  • Scientific Assessment
  • General Counsel/Corporate Counsel
  • Legal and Regulatory Compliance
  • Regulatory Affairs
  • Research and Development
  • Clinical Medicine
  • Clinical Operations
  • Lifecycle Management

This conference is also of interest to:

  • Investment Banks
  • Private Equity Firms
  • Venture Capitalists
  • Data Room Providers
  • Due Diligence Consultants
  • Law Firms
  • Clinical Affairs and CRO Partners
  • Regulatory Affairs and Compliance Partners
Startdate: 2020-02-24
End Date 2020-02-25

Description: The 2nd BD&L Summit for Life Sciences is the ONLY cross-functional life science event dedicated to the challenges faced by executives responsible for joint ventures, strategic alliances, M&A, and licensing deals.
Performer: ExL Events
Address : The 2nd BD&L Summit for Life Sciences